These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


332 related items for PubMed ID: 11357207

  • 1. Mass measles vaccination in urban Burkina Faso, 1998.
    Zuber PL, Conombo KS, Traoré AD, Millogo JD, Ouattara A, Ouédraogo IB, Valian A.
    Bull World Health Organ; 2001; 79(4):296-300. PubMed ID: 11357207
    [Abstract] [Full Text] [Related]

  • 2. Measles vaccination coverage during poliomyelitis national immunization days in Burkina Faso, 1999.
    Yaméogo KR, Yaméogo A, Nacoulma SD, Zuber PL.
    J Infect Dis; 2003 May 15; 187 Suppl 1():S74-9. PubMed ID: 12721895
    [Abstract] [Full Text] [Related]

  • 3. Measles incidence before and after mass vaccination campaigns in Burkina Faso.
    Kambiré C, Konde MK, Yaméogo A, Tiendrébéogo SR, Ouédraogo RT, Otten MW, Cairns KL, Zuber PL.
    J Infect Dis; 2003 May 15; 187 Suppl 1():S80-5. PubMed ID: 12721896
    [Abstract] [Full Text] [Related]

  • 4. Use of administrative data to estimate mass vaccination campaign coverage, Burkina Faso, 1999.
    Zuber PL, Yaméogo KR, Yaméogo A, Otten MW.
    J Infect Dis; 2003 May 15; 187 Suppl 1():S86-90. PubMed ID: 12721897
    [Abstract] [Full Text] [Related]

  • 5. Distributing insecticide-treated bednets during measles vaccination: a low-cost means of achieving high and equitable coverage.
    Grabowsky M, Nobiya T, Ahun M, Donna R, Lengor M, Zimmerman D, Ladd H, Hoekstra E, Bello A, Baffoe-Wilmot A, Amofah G.
    Bull World Health Organ; 2005 Mar 15; 83(3):195-201. PubMed ID: 15798843
    [Abstract] [Full Text] [Related]

  • 6. Migration as a risk factor for measles after a mass vaccination campaign, Burkina Faso, 2002.
    Yaméogo KR, Perry RT, Yaméogo A, Kambiré C, Kondé MK, Nshimirimana D, Kezaala R, Hersh BS, Cairns KL, Strebel P.
    Int J Epidemiol; 2005 Jun 15; 34(3):556-64. PubMed ID: 15659463
    [Abstract] [Full Text] [Related]

  • 7. Effect of several sociodemographic factors on measles immunization in children of Eastern Turkey.
    Altinkaynak S, Ertekin V, Güraksin A, Kiliç A.
    Public Health; 2004 Dec 15; 118(8):565-9. PubMed ID: 15530936
    [Abstract] [Full Text] [Related]

  • 8. Measles supplemental immunization activities improve measles vaccine coverage and equity: Evidence from Kenya, 2002.
    Vijayaraghavan M, Martin RM, Sangrujee N, Kimani GN, Oyombe S, Kalu A, Runyago A, Wanjau G, Cairns L, Muchiri SN.
    Health Policy; 2007 Sep 15; 83(1):27-36. PubMed ID: 17174435
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of urban measles mass campaigns for children aged 9-59 months in Mali.
    Kertesz DA, Touré K, Berthé A, Konaté Y, Bougoudogo F.
    J Infect Dis; 2003 May 15; 187 Suppl 1():S69-73. PubMed ID: 12721894
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Survey of measles vaccine coverage in Brazzaville].
    Bolanda D, Talani P, Nzaba P, Moudzeo H, Biahoua M, Mayanda H, Yala F.
    Bull Soc Pathol Exot; 2000 Apr 15; 93(2):123-4. PubMed ID: 10863618
    [Abstract] [Full Text] [Related]

  • 13. Serogroup A meningococcal conjugate (PsA-TT) vaccine coverage and measles vaccine coverage in Burkina Faso--implications for introduction of PsA-TT into the Expanded Programme on Immunization.
    Meyer SA, Kambou JL, Cohn A, Goodson JL, Flannery B, Medah I, Messonnier N, Novak R, Diomande F, Djingarey MH, Clark TA, Yameogo I, Fall A, Wannemuehler K.
    Vaccine; 2015 Mar 17; 33(12):1492-8. PubMed ID: 25636915
    [Abstract] [Full Text] [Related]

  • 14. Measles resurgence following a nationwide measles vaccination campaign in Nigeria, 2005-2008.
    Weldegebriel GG, Gasasira A, Harvey P, Masresha B, Goodson JL, Pate MA, Abanida E, Chevez A.
    J Infect Dis; 2011 Jul 17; 204 Suppl 1():S226-31. PubMed ID: 21666165
    [Abstract] [Full Text] [Related]

  • 15. Measles control in Maputo, Mozambique, using a single dose of Schwarz vaccine at age 9 months.
    Cutts FT, Monteiro O, Tabard P, Cliff J.
    Bull World Health Organ; 1994 Jul 17; 72(2):227-31. PubMed ID: 8205642
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Non-specific effect of measles vaccination on overall child mortality in an area of rural India with high vaccination coverage: a population-based case-control study.
    Kabir Z, Long J, Reddaiah VP, Kevany J, Kapoor SK.
    Bull World Health Organ; 2003 Jul 17; 81(4):244-50. PubMed ID: 12764490
    [Abstract] [Full Text] [Related]

  • 20. Serogroup A meningococcal conjugate vaccine coverage after the first national mass immunization campaign-Burkina Faso, 2011.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2012 Dec 21; 61(50):1022-4. PubMed ID: 23254256
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.